Emerging Biomarkers in Metabolomics: Advancements in Precision Health and Disease Diagnosis
Dang-Khoa Vo, Kieu The Loan Trinh, Hartmut Schlüter · 2024
Read Emerging Biomarkers in Metabolomics: Advancements in Precision Health and Disease Diagnosis by Dang-Khoa Vo, Kieu The Loan Trinh, Hartmut Schlüter (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11642057.txt.
Description
Dang-Khoa Vo, Kieu The Loan Trinh, and co-authors review how metabolomics, the study of small molecules in the body, is yielding new disease markers, in a 2024 paper. Such markers promise earlier detection and care matched to the individual. The review ranges across cancer, brain disorders, heart disease, and metabolic health.
In cancer, certain abnormal metabolites can flag disease early and track treatment response. For brain conditions like Alzheimer's and Parkinson's, molecule profiles may speed diagnosis and clarify mechanisms. Lipid markers help sort heart and metabolic patients into risk groups. The authors also weigh the roles of gut microbes and environmental exposure, then discuss validation hurdles on the road to routine clinical use.
Catalog record
| CREATOR | Dang-Khoa Vo, Kieu The Loan Trinh, Hartmut Schlüter |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 55 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |